Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Idarucizumab for the Reversal of Dabigatran.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Idarucizumab for the Reversal of Dabigatran.
Idarucizumab for the Reversal of Dabigatran. Ann Emerg Med. 2017 May; 69(5):554-558.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized
Antidotes
Antithrombins
Clinical Trials, Phase I as Topic
Dabigatran
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Prospective Studies
Randomized Controlled Trials as Topic
Young Adult
authors with profiles
Michael Gottlieb